Links Between Cancer Stem Cells and Epithelial-mesenchymal Transition

Overview

Journal Onco Targets Ther

Publisher Dove Medical Press

Specialty Oncology

Date 2015 Nov 4

PMID 26527883

Citations 83

Authors

Sha-Sha Wang

Jian Jiang

Xin-Hua Liang

Ya-Ling Tang

Affiliations

Soon will be listed here.

Abstract

The epithelial-mesenchymal transition (EMT) has been reported to be an important program that is often activated during the process of cancer invasion and metastasis. Cancer stem cells (CSCs) that can initiate and maintain cancer are also involved in invasion and metastasis of cancer. Recently, insights into the molecular mechanisms and functional features of mesenchymal cells have been greatly colored by findings that some of them have been endowed with the self-renewal trait associated with normal tissue stem cells and CSCs. Among cancer cells experiencing EMT, only some of the most competent CSCs will succeed in planting in another organ. In this paper, we review the molecular mechanism behind the link of EMT and CSCs in cancer progression.

Citing Articles

Targeting drug resistance in breast cancer: the potential of miRNA and nanotechnology-driven delivery systems.

Verma A, Patel K, Kumar A Nanoscale Adv. 2024; 6(24):6079-6095.

PMID: 39569336 PMC: 11575621. DOI: 10.1039/d4na00660g.

Cyclophilin A knockdown inhibits the proliferation and metastatic ability of AGS gastric cancer stem cells by downregulating CD147/STAT3/AKT/ERK and epithelial‑mesenchymal transition.

Cho H, Jung H Mol Med Rep. 2024; 31(1).

PMID: 39513611 PMC: 11551680. DOI: 10.3892/mmr.2024.13379.

The relationship between keratin 18 and epithelial-derived tumors: as a diagnostic marker, prognostic marker, and its role in tumorigenesis.

Yan J, Yang A, Tu S Front Oncol. 2024; 14:1445978.

PMID: 39502314 PMC: 11534658. DOI: 10.3389/fonc.2024.1445978.

Role of Autophagy and AMPK in Cancer Stem Cells: Therapeutic Opportunities and Obstacles in Cancer.

Kovale L, Singh M, Kim J, Ha J Int J Mol Sci. 2024; 25(16).

PMID: 39201332 PMC: 11354724. DOI: 10.3390/ijms25168647.

Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies.

Romaniuk-Drapala A, Toton E, Taube M, Idzik M, Rubis B, Lisiak N Cancers (Basel). 2024; 16(13).

PMID: 39001543 PMC: 11240630. DOI: 10.3390/cancers16132481.

References

Shimono Y, Zabala M, Cho R, Lobo N, Dalerba P, Qian D . Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell. 2009; 138(3):592-603. PMC: 2731699. DOI: 10.1016/j.cell.2009.07.011. View

Mishra L, Derynck R, Mishra B . Transforming growth factor-beta signaling in stem cells and cancer. Science. 2005; 310(5745):68-71. DOI: 10.1126/science.1118389. View

Giannoni E, Bianchini F, Masieri L, Serni S, Torre E, Calorini L . Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res. 2010; 70(17):6945-56. DOI: 10.1158/0008-5472.CAN-10-0785. View

Bermejo-Rodriguez C, Perez-Caro M, Perez-Mancera P, Sanchez-Beato M, Piris M, Sanchez-Garcia I . Mouse cDNA microarray analysis uncovers Slug targets in mouse embryonic fibroblasts. Genomics. 2005; 87(1):113-8. DOI: 10.1016/j.ygeno.2005.09.014. View

You H, Ding W, Dang H, Jiang Y, Rountree C . c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma. Hepatology. 2011; 54(3):879-89. PMC: 3181384. DOI: 10.1002/hep.24450. View

Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View

Li C, Heidt D, Dalerba P, Burant C, Zhang L, Adsay V . Identification of pancreatic cancer stem cells. Cancer Res. 2007; 67(3):1030-7. DOI: 10.1158/0008-5472.CAN-06-2030. View

Battula V, Evans K, Hollier B, Shi Y, Marini F, Ayyanan A . Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem Cells. 2010; 28(8):1435-45. PMC: 3523728. DOI: 10.1002/stem.467. View

Zhang X, Zhao X, Shao S, Zuo X, Ning Q, Luo M . Notch1 induces epithelial-mesenchymal transition and the cancer stem cell phenotype in breast cancer cells and STAT3 plays a key role. Int J Oncol. 2014; 46(3):1141-8. DOI: 10.3892/ijo.2014.2809. View

10.

Sarkar F, Li Y, Wang Z, Kong D . Pancreatic cancer stem cells and EMT in drug resistance and metastasis. Minerva Chir. 2009; 64(5):489-500. PMC: 2878773. View

11.

Chiou S, Wang M, Chou Y, Chen C, Hong C, Hsieh W . Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation. Cancer Res. 2010; 70(24):10433-44. DOI: 10.1158/0008-5472.CAN-10-2638. View

12.

Fang X, Cai Y, Liu J, Wang Z, Wu Q, Zhang Z . Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal. Oncogene. 2011; 30(47):4707-20. DOI: 10.1038/onc.2011.181. View

13.

To K, Fotovati A, Reipas K, Law J, Hu K, Wang J . Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance. Cancer Res. 2010; 70(7):2840-51. PMC: 2848879. DOI: 10.1158/0008-5472.CAN-09-3155. View

14.

Liu S, Dontu G, Mantle I, Patel S, Ahn N, Jackson K . Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 2006; 66(12):6063-71. PMC: 4386278. DOI: 10.1158/0008-5472.CAN-06-0054. View

15.

Wang H, Wu J, Zhang Y, Xue X, Tang D, Yuan Z . Transforming growth factor β-induced epithelial-mesenchymal transition increases cancer stem-like cells in the PANC-1 cell line. Oncol Lett. 2012; 3(1):229-233. PMC: 3362468. DOI: 10.3892/ol.2011.448. View

16.

May C, Sphyris N, Evans K, Werden S, Guo W, Mani S . Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression. Breast Cancer Res. 2011; 13(1):202. PMC: 3109556. DOI: 10.1186/bcr2789. View

17.

Wu Y, Zhou B . Inflammation: a driving force speeds cancer metastasis. Cell Cycle. 2009; 8(20):3267-73. PMC: 3702728. DOI: 10.4161/cc.8.20.9699. View

18.

Kotiyal S, Bhattacharya S . Breast cancer stem cells, EMT and therapeutic targets. Biochem Biophys Res Commun. 2014; 453(1):112-6. DOI: 10.1016/j.bbrc.2014.09.069. View

19.

Singh A, Greninger P, Rhodes D, Koopman L, Violette S, Bardeesy N . A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. Cancer Cell. 2009; 15(6):489-500. PMC: 2743093. DOI: 10.1016/j.ccr.2009.03.022. View

20.

Yang M, Wu K . TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development. Cell Cycle. 2008; 7(14):2090-6. DOI: 10.4161/cc.7.14.6324. View